Efor launches Valimate, its artificial intelligence platform dedicated to compliance and validation in Life Sciences

A new step in the transformation of compliance

Artificial intelligence is already transforming Life Sciences in depth. It accelerates research, optimizes manufacturing processes, and helps shorten the time between innovation and patient access to treatments.

But in a sector where every decision has a direct impact on the quality and safety of health products, innovation cannot happen without mastering compliance.

This conviction is what gave rise to Efor Valimate, the new artificial intelligence platform developed by Efor to support Commissioning, Qualification & Validation (CQV) professionals.

Designed by CQV experts, for CQV experts, Efor Valimate marks a new step in our ambition: putting technology at the service of human expertise to improve the quality, compliance, and performance of projects.

AI as an accelerator of expertise

At Efor, we are convinced that artificial intelligence will never replace expert judgment.

Field experience, critical analysis, knowledge of regulatory requirements, and accountability for decisions will always remain at the heart of quality and validation professions. However, AI can significantly strengthen their efficiency.

By automating the most repetitive tasks, structuring information, and facilitating document production, it allows teams to devote more time to high-value activities: analyzing, deciding, securing, and supporting projects.

The future is not an opposition between humans and technology.

It relies on experts empowered by tools capable of amplifying their know-how.

A platform designed for CQV professionals

Efor Valimate is not a generalist artificial intelligence tool.

It is a specialized platform, developed specifically to address the compliance challenges of Life Sciences.

Through a “validation-ready” approach, Valimate supports teams throughout CQV activities, notably enabling them to:

• generate validation protocols and reports faster
• improve the consistency and robustness of documents from their first draft
• identify potential deviations earlier
• strengthen audit readiness
• reduce cycle times while maintaining a high level of quality requirements

The objective is simple: eliminate low-value tasks so experts can focus on their true role.

Responsible AI, developed by Life Sciences experts

The performance of an artificial intelligence depends above all on the expertise that feeds it.

That is why Valimate was conceived and developed internally by Efor’s teams, in collaboration with senior Life Sciences specialists.

Their operational experience and mastery of regulatory requirements are directly built into the platform.

Our approach rests on a fundamental principle: artificial intelligence assists experts, but critical decisions remain under human responsibility.

This complementarity ensures reliable, traceable results that meet regulatory expectations.

An innovation serving time-to-patient

In Life Sciences, saving time only makes sense if quality and safety are preserved.

By improving the efficiency of validation and compliance activities, Valimate helps address one of the industry’s greatest challenges: reducing time-to-patient without ever compromising regulatory requirements.

Every optimized process, every document produced more efficiently, and every decision made with greater reliability contribute to a broader goal: enabling therapeutic innovations to reach patients faster, under the best conditions of quality and safety.

With Efor Valimate, Efor confirms its ambition: to support the industry’s digital transformation by developing tools that strengthen human expertise, accelerate projects, and help build a smarter, safer, and more high-performing future for Life Sciences.